UB Paderborn / Katalog / Suche / in CDI

Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial

Nature medicine, 2022-02, Vol.28 (2), p.325-332

2022

Link zum Volltext

Verfügbarkeit prüfen

Landscape of HER2-low metastatic breast cancer (MBC): results from the Austrian AGMT_MBC-Registry

Breast cancer research : BCR, 2021-12, Vol.23 (1), p.112-112, Article 112

2021

Link zum Volltext

Verfügbarkeit prüfen

Current concepts of anti-EGFR targeting in metastatic colorectal cancer

Frontiers in oncology, 2022-11, Vol.12, p.1048166-1048166

2022

Link zum Volltext

Verfügbarkeit prüfen

The EndoPredict score predicts response to neoadjuvant chemotherapy and neoendocrine therapy in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients from the ABCSG-34 trial

European journal of cancer (1990), 2020-07, Vol.134, p.99-106

2020

Link zum Volltext

Verfügbarkeit prüfen

Characterization of a newly identified ETV6-NTRK3 fusion transcript in acute myeloid leukemia

Diagnostic pathology, 2011-03, Vol.6 (1), p.19-19, Article 19

2011

Link zum Volltext

Verfügbarkeit prüfen

Abstract P1-16-03: Response pattern to chemotherapy in metastatic breast cancer (MBC): Real-word data from the Austrian AGMT_MBC-Registry

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P1-P1-16-03

2022

Link zum Volltext

Verfügbarkeit prüfen

Total body irradiation with volumetric modulated arc therapy: Dosimetric data and first clinical experience

Radiation oncology (London, England), 2016-03, Vol.11 (1), p.46, Article 46

2016

Link zum Volltext

Verfügbarkeit prüfen

Prospective Evaluation of Allogeneic Hematopoietic Stem-Cell Transplantation From Matched Related and Matched Unrelated Donors in Younger Adults With High-Risk Acute Myeloid Leukemia: German-Austrian Trial AMLHD98A

Journal of clinical oncology, 2010-10, Vol.28 (30), p.4642-4648

2010

Link zum Volltext

Verfügbarkeit prüfen

Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update

Blood, 2024-04, Vol.143 (17), p.1713

2024

Link zum Volltext

Verfügbarkeit prüfen

Conventional versus reverse sequence of neoadjuvant epirubicin/cyclophosphamide and docetaxel: sequencing results from ABCSG-34

British journal of cancer, 2021-05, Vol.124 (11), p.1795-1802

2021

Link zum Volltext

Verfügbarkeit prüfen

Prediction of response to systemic treatment by kinetics of circulating tumor DNA in metastatic pancreatic cancer

Frontiers in oncology, 2022-08, Vol.12, p.902177-902177

2022

Link zum Volltext

Verfügbarkeit prüfen

Real world evidence reveals improved survival outcomes in biliary tract cancer through molecular matched targeted treatment

Scientific reports, 2023-09, Vol.13 (1), p.15421-15421, Article 15421

2023

Link zum Volltext

Verfügbarkeit prüfen

MicroRNAs and their role for T stage determination and lymph node metastasis in early colon carcinoma

Clinical & experimental metastasis, 2017-10, Vol.34 (6-7), p.431-440

2017

Link zum Volltext

Verfügbarkeit prüfen

Altered fractionation short-course radiotherapy for stage II-III rectal cancer: a retrospective study

Radiation oncology (London, England), 2020-05, Vol.15 (1), p.111-111, Article 111

2020

Link zum Volltext

Verfügbarkeit prüfen

Risk Factors for Local Relapse and Inferior Disease-free Survival After Breast-conserving Management of Breast Cancer: Recursive Partitioning Analysis of 2161 Patients

Clinical breast cancer, 2019-02, Vol.19 (1), p.58-62

2019

Link zum Volltext

Verfügbarkeit prüfen

Clinical Effectiveness of Oncological Treatment in Metastatic Colorectal Cancer Is Independent of Comorbidities and Age

Cancers, 2021-04, Vol.13 (9), p.2091

2021

Link zum Volltext

Verfügbarkeit prüfen

Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial)

BMC cancer, 2018-11, Vol.18 (1), p.1074-1074, Article 1074

2018

Link zum Volltext

Verfügbarkeit prüfen

The Agony of Choice—Where to Place the Wave of BCMA-Targeted Therapies in the Multiple Myeloma Treatment Puzzle in 2022 and Beyond

Cancers, 2021-09, Vol.13 (18), p.4701

2021

Link zum Volltext

Verfügbarkeit prüfen

Response prediction by mutation- or methylation-specific detection of ctDNA dynamics in pretreated metastatic colorectal cancer

Therapeutic advances in medical oncology, 2023-01, Vol.15, p.17588359231200462-17588359231200462

2023

Link zum Volltext

Verfügbarkeit prüfen

ASCO update—best of the best

Memo - Magazine of European medical oncology, 2022, Vol.15 (4), p.255-256

Petzer, Andreas

2022

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial

Landscape of HER2-low metastatic breast cancer (MBC): results from the Austrian AGMT_MBC-Registry

Current concepts of anti-EGFR targeting in metastatic colorectal cancer

The EndoPredict score predicts response to neoadjuvant chemotherapy and neoendocrine therapy in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients from the ABCSG-34 trial

Characterization of a newly identified ETV6-NTRK3 fusion transcript in acute myeloid leukemia

Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34)

Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG)

Abstract P1-16-03: Response pattern to chemotherapy in metastatic breast cancer (MBC): Real-word data from the Austrian AGMT_MBC-Registry

Total body irradiation with volumetric modulated arc therapy: Dosimetric data and first clinical experience

Prospective Evaluation of Allogeneic Hematopoietic Stem-Cell Transplantation From Matched Related and Matched Unrelated Donors in Younger Adults With High-Risk Acute Myeloid Leukemia: German-Austrian Trial AMLHD98A

Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update

Definitions, methodological and statistical issues for phase 3 clinical trials in chronic myeloid leukemia: a proposal by the European LeukemiaNet

Conventional versus reverse sequence of neoadjuvant epirubicin/cyclophosphamide and docetaxel: sequencing results from ABCSG-34

Prediction of response to systemic treatment by kinetics of circulating tumor DNA in metastatic pancreatic cancer

Real world evidence reveals improved survival outcomes in biliary tract cancer through molecular matched targeted treatment

MicroRNAs and their role for T stage determination and lymph node metastasis in early colon carcinoma

Salvage therapy with high-dose cytarabine and mitoxantrone in combination with all-trans retinoic acid and gemtuzumab ozogamicin in acute myeloid leukemia refractory to first induction therapy

Altered fractionation short-course radiotherapy for stage II-III rectal cancer: a retrospective study

Allogeneic Stem Cell Transplantation in Multiple Myeloma: Risk Factors and Outcomes in the Era of New Therapeutic Options-A Single-Center Experience

Risk Factors for Local Relapse and Inferior Disease-free Survival After Breast-conserving Management of Breast Cancer: Recursive Partitioning Analysis of 2161 Patients

Clinical Effectiveness of Oncological Treatment in Metastatic Colorectal Cancer Is Independent of Comorbidities and Age

Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial)

The Agony of Choice—Where to Place the Wave of BCMA-Targeted Therapies in the Multiple Myeloma Treatment Puzzle in 2022 and Beyond

Response prediction by mutation- or methylation-specific detection of ctDNA dynamics in pretreated metastatic colorectal cancer

ASCO update—best of the best

Suchergebnisse filtern